Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obesity

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 39 articles:
HTML format



Single Articles


    September 2022
  1. VILACA T, Evans A, Gossiel F, Paggiosi M, et al
    Fat, adipokines, bone structure and bone regulatory factors associations in obesity.
    Eur J Endocrinol. 2022 Sep 1. pii: EJE-22-0530. doi: 10.1530/EJE-22-0530.
    PubMed     Abstract available


    June 2022
  2. ROSEN CJ
    3E: My Quarter Century Quest to Understand the Paradox of Marrow Adiposity.
    Eur J Endocrinol. 2022 Jun 1. pii: EJE-22-0499. doi: 10.1530/EJE-22-0499.
    PubMed     Abstract available


    May 2022
  3. BLAGOJEVIC C, Heung T, Malecki S, Ying S, et al
    Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.
    Eur J Endocrinol. 2022;187:91-99.
    PubMed     Abstract available


    April 2022
  4. MATHIESEN DS, Lund A, Holst JJ, Knop FK, et al
    THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology.
    Eur J Endocrinol. 2022;186:R93-R111.
    PubMed     Abstract available


  5. GOEDEGEBUURE WJ, van der Steen M, Smeets CCJ, Kerkhof GF, et al
    SGA-born adults with postnatal catch-up have a persistently unfavorable metabolic health profile and increased adiposity at age 32 years.
    Eur J Endocrinol. 2022 Apr 1. pii: EJE-21-1130. doi: 10.1530/EJE-21-1130.
    PubMed     Abstract available


    March 2022
  6. HUYNH K, Klose M, Krogsgaard K, Drejer J, et al
    Randomized Controlled Trial of Tesomet for Weight Loss in Hypothalamic Obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0972. doi: 10.1530/EJE-21-0972.
    PubMed     Abstract available


  7. RUIZ S, Vazquez F, Pellitero S, Puig Domingo M, et al
    Pituitary dysfunction in obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-0899. doi: 10.1530/EJE-21-0899.
    PubMed     Abstract available


  8. DICHTEL LE, Haines MS, Gerweck AV, Bollinger B, et al
    Impact of GH administration on skeletal endpoints in adults with overweight/obesity.
    Eur J Endocrinol. 2022 Mar 1. pii: EJE-21-1061. doi: 10.1530/EJE-21-1061.
    PubMed     Abstract available


    February 2022
  9. KOH HE, van Vliet S, Cao C, Patterson BW, et al
    Effect of obstructive sleep apnea on glucose metabolism.
    Eur J Endocrinol. 2022;186:457-467.
    PubMed     Abstract available


  10. LAUGESEN K, Sorensen HT, Jorgensen JOL, Petersen I, et al
    Prenatal exposure to glucocorticoids and the prevalence of overweight or obesity in childhood.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0846.R1. doi: 10.1530/EJE-21-0846.
    PubMed     Abstract available


  11. DHINDSA S, Ghanim H, Jenkins T, Inge TH, et al
    High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery.
    Eur J Endocrinol. 2022;186:319-327.
    PubMed     Abstract available


  12. KUFE C, Micklesfield LK, Masemola M, Chikowore T, et al
    Increased Risk for Type 2 Diabetes in Relation to Adiposity in Middle-Aged Black South African Men compared to Women.
    Eur J Endocrinol. 2022 Feb 1. pii: EJE-21-0527. doi: 10.1530/EJE-21-0527.
    PubMed     Abstract available


    January 2022
  13. LOH NY, Humphreys E, Karpe F, Tomlinson JW, et al
    Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian Randomisation study.
    Eur J Endocrinol. 2022 Jan 1. pii: EJE-21-0703.R2. doi: 10.1530/EJE-21-0703.
    PubMed     Abstract available


    December 2021
  14. SONG Z, Gao M, Lv J, Yu C, et al
    Metabolically healthy obesity, transition to unhealthy phenotypes and type 2 diabetes in 0.5 million Chinese adults: The China Kadoorie Biobank.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0743.R1. doi: 10.1530/EJE-21-0743.
    PubMed     Abstract available


  15. MAN S, Gao Y, Lv J, Tong M, et al
    Metabolically healthy obesity was significantly associated with increased risk of gallstones.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0802.R2. doi: 10.1530/EJE-21-0802.
    PubMed     Abstract available


  16. MOHSENI-TAKALLOO S, Beigrezaei S, Yazdanpanah Z, Rajaie SH, et al
    Does exercise beneficially affect sex hormones when added to hypo-caloric diets in adults with overweight or obesity? A systematic review and meta-analysis of controlled clinical trials.
    Eur J Endocrinol. 2021 Dec 1. pii: EJE-21-0675.R1. doi: 10.1530/EJE-21-0675.
    PubMed     Abstract available


    November 2021
  17. DIETZ DE LOOS A, Jiskoot G, Beerthuizen A, Busschbach J, et al
    Metabolic health during a randomized controlled lifestyle intervention in women with PCOS.
    Eur J Endocrinol. 2021;186:53-64.
    PubMed     Abstract available


  18. RUSSELL N, Hoermann R, Cheung AS, Zajac JD, et al
    Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
    Eur J Endocrinol. 2021;186:9-23.
    PubMed     Abstract available


  19. ZHANG J, Chen X, Liu W, Zhang C, et al
    Metabolic surgery improves the unbalanced proportion of peripheral blood myeloid dendritic cells and T lymphocytes in obese patients.
    Eur J Endocrinol. 2021;185:819-829.
    PubMed     Abstract available


  20. MANGOLIM AS, Brito LAR, Nunes-Nogueira VDS
    Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0473.R1. doi: 10.1530/EJE-21-0473.
    PubMed     Abstract available


  21. YANG R, Hu Y, Lee CH, Liu Y, et al
    PM20D1 Is a Circulating Biomarker Closely Associated with Obesity, Insulin resistance and Metabolic Syndrome.
    Eur J Endocrinol. 2021 Nov 1. pii: EJE-21-0847.R1. doi: 10.1530/EJE-21-0847.
    PubMed     Abstract available


    October 2021
  22. ROMERO-RUIZ A, Pineda B, Ovelleiro D, Perdices-Lopez C, et al
    Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.
    Eur J Endocrinol. 2021;185:637-652.
    PubMed     Abstract available


    September 2021
  23. ANDERSEN MR, Suppli MP, Bagger JI, Christensen MB, et al
    MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.
    Eur J Endocrinol. 2021;185:R93-R101.
    PubMed     Abstract available


    August 2021
  24. NOGUEIRAS R
    MECHANISMS IN ENDOCRINOLOGY: The gut-brain axis: regulating energy balance independent of food intake.
    Eur J Endocrinol. 2021;185:R75-R91.
    PubMed     Abstract available


    June 2021
  25. LEITER A, Carroll E, De Alwis S, Brooks D, et al
    Metabolic disease and adverse events from immune checkpoint inhibitors.
    Eur J Endocrinol. 2021;184:857-865.
    PubMed     Abstract available


    May 2021
  26. GROOTJEN LN, Rutges JPHJ, Damen L, Donze SH, et al
    Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2021;185:47-55.
    PubMed     Abstract available


  27. DAMEN L, Grootjen LN, Donze SH, de Graaff LCG, et al
    Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
    Eur J Endocrinol. 2021;184:773-782.
    PubMed     Abstract available


  28. MCNEILL BT, Suchacki KJ, Stimson RH
    MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?
    Eur J Endocrinol. 2021;184:R243-R259.
    PubMed     Abstract available


  29. SUBRAMANIAN A, Anand A, Adderley NJ, Okoth K, et al
    Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Eur J Endocrinol. 2021;184:637-645.
    PubMed     Abstract available


  30. DE ZEGHER F, Ibanez L
    On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0287. doi: 10.1530/EJE-21-0287.
    PubMed     Abstract available


  31. LEGER J, Delcour C, De Roux N, Carel JC, et al
    Response to letter to the editor (from De Zegher and Ibanes) (On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls).
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0445. doi: 10.1530/EJE-21-0445.
    PubMed     Abstract available


    April 2021
  32. REYES M, Gonzalez L, Ibeas K, Cereijo R, et al
    White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage.
    Eur J Endocrinol. 2021;184:533-541.
    PubMed     Abstract available


  33. JUN JE, Kang M, Jin SM, Kim K, et al
    Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-0885.R1. doi: 10.1530/EJE-20-0885.
    PubMed     Abstract available


  34. STENSEN S, Gasbjerg LS, Krogh LL, Skov-Jeppesen K, et al
    Effects of endogenous GIP in patients with type 2 diabetes.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0135.R1. doi: 10.1530/EJE-21-0135.
    PubMed     Abstract available


    January 2021
  35. VALDES N, Tirosh A, Keil M, Stratakis CA, et al
    Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factors.
    Eur J Endocrinol. 2021;184:179-187.
    PubMed     Abstract available


    December 2020
  36. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    PubMed     Abstract available


    November 2020
  37. BEAVERS KM, Greene KA, Yu EW
    MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.
    Eur J Endocrinol. 2020;183:R119-R132.
    PubMed     Abstract available


  38. POITOU C, Mosbah H, Clement K
    MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
    Eur J Endocrinol. 2020;183:R149-R166.
    PubMed     Abstract available


    September 2020
  39. VAN DER VALK ES, van der Voorn B, Iyer AM, van den Berg S, et al
    In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone.
    Eur J Endocrinol. 2020 Sep 1. pii: EJE-20-0077.R1. doi: 10.1530/EJE-20-0077.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: